The effect of expressive writing on the anxiety and resilience of family caregivers of patients undergoing chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240707062354N1

Enrollment

Registered

2025-02-06

Start date

2025-01-31

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and resilience of family caregivers of patients undergoing chemotherapy.

Interventions

Intervention 1: Intervention group: The participants of intervention group will be asked to write about 15 to 30 minutes a day about the most anxiety event in their lives for four consecutive weeks. I

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study age 18-65 years able to read and write not having psychological problems not taking anti-anxiety drugs, opioids or strong painkillers according to the Spielberger Anxiety Questionnaire, the research unit should have moderate to severe anxiety The patient must be in the chemotherapy phase the person's resilience score is lower than 50 based on the Connor and Davidson questionnaire.

Exclusion criteria

Exclusion criteria: Failure to fully implement the intervention by the research unit Death of the patient during the implementation of the intervention

Design outcomes

Primary

Measure	Time frame
Anxiety score in the Spielberger Anxiety Questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (4 weeks after the start of the intervention). Method of measurement: Spielberger anxiety questionnaire.;Resilience based on Connor and Davidson resilience questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (4 weeks later). Method of measurement: Connor and Davidson Resilience Questionnaire.	—

Measure

Time frame

Anxiety score in the Spielberger Anxiety Questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (4 weeks after the start of the intervention). Method of measurement: Spielberger anxiety questionnaire.;Resilience based on Connor and Davidson resilience questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (4 weeks later). Method of measurement: Connor and Davidson Resilience Questionnaire.

—

Secondary

Measure	Time frame
The level of anxiety based on the Spielberger anxiety questionnaire at the end of the intervention. Timepoint: End of intervention. Method of measurement: Spielberger anxiety questionnaire.;The degree of resilience based on the Connor and Davidson resilience questionnaire at the end of the intervention. Timepoint: End of intervention. Method of measurement: Connor and Davidson resilience questionnaire.	—

Measure

Time frame

The level of anxiety based on the Spielberger anxiety questionnaire at the end of the intervention. Timepoint: End of intervention. Method of measurement: Spielberger anxiety questionnaire.;The degree of resilience based on the Connor and Davidson resilience questionnaire at the end of the intervention. Timepoint: End of intervention. Method of measurement: Connor and Davidson resilience questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Moghadasi

Arak University of Medical Sciences

fatemehmoghadasi03@gmail.com+98 86 3221 9231

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026